Dan Benjamin Teleman, CEO of Nasus Pharma NSRX, has filed 3 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $61.8K. The latest trade was on 06/17.

DT

DT

Dan Benjamin Teleman

CEO

Company

Nasus Pharma NSRX

First filing

26/04/01

Trades

3 trades

Buys / sales

3 / 0

12-month net buying

$61.8K

Last trade

06/17

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Nasus PharmaNSRX	Open-market buy	06/17	06/22	6,550 sh	$3.10	$20,305	+4.2%
Nasus PharmaNSRX	Open-market buy	04/22	04/22	2,900 sh	$3.76	$10,904	+1.9%
Nasus PharmaNSRX	Open-market buy	03/31	04/01	15,000 sh	$2.04	$30,600	+240.2%